| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adenovirus-uteroglobin suppresses COX-2 expression via inhibition of NF-κB activity in lung cancer cells
|
Yoon, Jung Min
|
|
2005
|
48 |
2 |
p. 201-209
9 p.
|
artikel
|
| 2 |
Corrigendum to “VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer” [Lung Cancer 46 (2003) 293–298]
|
Koukourakis, Michael I.
|
|
2005
|
48 |
2 |
p. 297-
1 p.
|
artikel
|
| 3 |
Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting
|
Manser, Renee
|
|
2005
|
48 |
2 |
p. 171-185
15 p.
|
artikel
|
| 4 |
Detection of autoantibodies to livin and survivin in Sera from lung cancer patients
|
Yagihashi, Atsuhito
|
|
2005
|
48 |
2 |
p. 217-221
5 p.
|
artikel
|
| 5 |
Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial
|
Nugent, Francis W.
|
|
2005
|
48 |
2 |
p. 267-273
7 p.
|
artikel
|
| 6 |
Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer
|
Junker, Nanna
|
|
2005
|
48 |
2 |
p. 223-231
9 p.
|
artikel
|
| 7 |
Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years
|
Skuladottir, Halla
|
|
2005
|
48 |
2 |
p. 187-199
13 p.
|
artikel
|
| 8 |
Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial
|
D’Cunha, Jonathan
|
|
2005
|
48 |
2 |
p. 241-246
6 p.
|
artikel
|
| 9 |
pre ix: Calendar of Events
|
|
|
2005
|
48 |
2 |
p. ix-
1 p.
|
artikel
|
| 10 |
pre v: Contents
|
|
|
2005
|
48 |
2 |
p. v-
1 p.
|
artikel
|
| 11 |
pre vi : Contents continued
|
|
|
2005
|
48 |
2 |
p. vi-
1 p.
|
artikel
|
| 12 |
Quantitative evaluation of the apoptosis regulating genes Survivin, Bcl-2 and Bax in inflammatory and malignant pleural lesions
|
Falleni, Monica
|
|
2005
|
48 |
2 |
p. 211-216
6 p.
|
artikel
|
| 13 |
Second-line chemotherapy in recurrent small cell lung cancer
|
Sundstrøm, Stein
|
|
2005
|
48 |
2 |
p. 251-261
11 p.
|
artikel
|
| 14 |
Second-line for small cell lung cancer: how-to-do-it?
|
Postmus, Pieter E.
|
|
2005
|
48 |
2 |
p. 263-265
3 p.
|
artikel
|
| 15 |
Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary
|
Maziak, Donna E.
|
|
2005
|
48 |
2 |
p. 157-169
13 p.
|
artikel
|
| 16 |
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials
|
Kuo, Sung-Hsin
|
|
2005
|
48 |
2 |
p. 275-280
6 p.
|
artikel
|
| 17 |
Thalidomide in patients with malignant pleural mesothelioma
|
Baas, Paul
|
|
2005
|
48 |
2 |
p. 291-296
6 p.
|
artikel
|
| 18 |
Transesophageal endoscopic ultrasound/fine-needle aspiration diagnosis of a malignant adrenal gland in a patient with non-small cell lung cancer and a negative CT scan
|
Ringbaek, T.J.
|
|
2005
|
48 |
2 |
p. 247-249
3 p.
|
artikel
|
| 19 |
Tumor specific expression of survivin-2B in lung cancer as a novel target of immunotherapy
|
Ichiki, Yoshinobu
|
|
2005
|
48 |
2 |
p. 281-289
9 p.
|
artikel
|
| 20 |
Tumour CEA as predictor of better outcome in squamous cell carcinoma of the lung
|
Veronesi, Giulia
|
|
2005
|
48 |
2 |
p. 233-240
8 p.
|
artikel
|
Tijdschrift beschrijving